BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Minority Interest

Track Telomir Pharmaceuticals's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer trimmed avg / median

Loading

Telomir Pharmaceuticals Minority Interest History

Loading

Telomir Pharmaceuticals vs. peers: Minority Interest Comparison

Loading

Telomir Pharmaceuticals Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Telomir Pharmaceuticals (TELO) FAQ

The latest minority interest for TELO is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Telomir Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, TELO's minority interest moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Telomir Pharmaceuticals's operating scale or balance-sheet position.

A minority interest figure of $0 for TELO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TELO's minority interest ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.